LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Inicio・Lista de Acciones・Codexis Inc

Codexis Inc

Cerrado

SectorSanidad

2.48 -2.36

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

2.44

Máximo

2.49

Métricas clave
By Trading Economics
Ingresos	-18M -8.7M
Ventas	-24M 15M
BPA	-0.1
Margen de beneficios	-57.083
Empleados	146
EBITDA	-23M -5.8M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+177.11% upside

Dividendos
By Dow Jones
Próximas Ganancias	12 ago 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	3.6M 232M
Apertura anterior	4.84
Cierre anterior	2.48

Noticias sobre sentimiento de mercado

By Acuity

100%

326 / 345 Clasificación en Healthcare

Codexis Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

6 nov 2025, 21:37 UTC

Ganancias

Codexis to Cut About 24% of Workforce

Comparación entre iguales

Cambio de precio

Codexis Inc previsión

Precio Objetivo

By TipRanks

177.11% repunte

Estimación a 12 Meses

Media 6.9 USD 177.11%

Máximo 11 USD

Mínimo 2 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Codexis Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para Codexis Inc Dist en los últimos 3 meses.

Sentimiento

By Acuity

326 / 345 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.